The new Remote program was recently tested by the Ealick lab at Cornell. A typical 22 hour shift was completed with only minor bugs. Of great benefit was the feedback from the remote users, which will be used to improve the interface before rollout in Run2 2012.Remote access for 24ID-E will be available for Run 2 of 2012.
SARS-CoV-2 is a zoonotic virus that has caused a pandemic of severe respiratory disease—COVID-19— within several months of its initial identification. Comparable to the first SARS-CoV, this novel coronavirus’s surface Spike (S) glycoprotein mediates cell entry via the human ACE-2 receptor, and, thus, is the principal target for the development of vaccines and immunotherapeutics.